Cardior Pharmaceuticals
Presence
Novo Nordisk is one of the...
Novo Nordisk is a company listed under the stock ticker NOVO (DK).
Novo Nordisk has a direct presence in 11 countries.Novo Nordisk has 16 subsidiaries including Cardior Pharmaceuticals, Dicerna Pharmaceuticals and Inversago Pharma.
They are in:
- Pharmaceuticals71%
- Biotechnology12%
- Other18%
Acquisition, funding and merger involving Novo Nordisk.
- Novo Nordisk has announced the acquisition of Inversago Pharma (posted on August 15 2023).
- Novo Nordisk has announced the acquisition of Forma Therapeutics (posted on September 5 2022).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at Cardior Pharmaceuticals
Create your alert
to follow the executive moves at Cardior Pharmaceuticals.
Pharmaceuticals
Novo Nordisk has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Cardior Pharmaceuticals
Social media about Cardior Pharmaceuticals
- Cardior Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Cardior Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Claudia Ulbrich 
